Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenishaw Regulatory News (RSW)

Share Price Information for Renishaw (RSW)

Share Price is delayed by 15 minutes
Get Live Data
5,415.00    -40.00 (-0.73%)
Bid:
5,415.00
Ask:
5,425.00
Spread: 10.00 (0.185%)
Market Cap: £3.94b
RSW Live PriceLast checked at - London Stock Exchange

Intraday Renishaw Share Chart

Interim Management Statement

17 Oct 2013 10:55

RNS Number : 7496Q
Renishaw PLC
17 October 2013
 



Renishaw plc

Interim management statement

 

This statement has been prepared for the Group and relates to the three months ended 30th September 2013. It contains unaudited information that covers the first quarter and the period since.

 

Trading activity

As highlighted in my year-end statement, in July 2013, the tough comparators facing the Group in the first half of this financial year following record first half revenue last year have proven to be the case with revenue for the three months to 30th September 2013 of £79.0m (2012 £95.9m). Excluding major sales in the first quarter last year, referred to below, we experienced an underlying growth of 9%.

 

By business segment, our metrology business reported revenue of £75.2m, compared with £92.2m for the comparable period last year and our healthcare revenue was similar to last year at £3.8m (2012 £3.7m).

 

Geographically, we experienced good growth of 18% in the Americas and growth of 6% in Europe compared with the corresponding period last year. The Far East, specifically China, continues to be our largest region but revenue suffered a 40% reduction compared with last year, which had benefited from major sales to the consumer electronics industry. The UK, a smaller geographical area in terms of revenue, showed a 9% decrease.

 

The Group cost base in the three months increased by 5% reflecting inflationary increases and expansion of our global marketing and distribution infrastructure. Group headcount at the end of September 2013 was 3,311, an increase of 76 from the 3,235 at the start of the financial year at 1st July 2013, which includes a significant intake of graduates and apprentices.

 

Profit before tax for the first quarter amounted to £10.6m, compared with £27.7m last year as restated from £28.3m to reflect the amendment to accounting standard IAS 19 regarding pension accounting.

 

Significant events and financial position

There has been no significant capital expenditure during the period although at New Mills, the construction of a 120,000 sq ft facility to provide expansion for additional research and development activities, product display, training and conference facilities and the relocation of the spectroscopy product line, commenced in April this year and is progressing, with completion due at the beginning of the next financial year.

 

The Group balance sheet remains strong with net cash balances, excluding the escrow account relating to security for the UK defined benefit pension scheme, at 30th September 2013 of £30.2m (30th June 2013 £26.6m).

 

Board

As already notified in our annual report mailing, Bill Whiteley, the senior independent director, has decided not to seek re-election. Bill has contributed to the growth and success of Renishaw during his 5-year appointment and we wish him every success in the future. We are in the process of recruiting a replacement non-executive director.

 

I am pleased that David Grant has agreed to become acting senior independent director whilst we undergo the recruitment process. Following the new appointment we will review the board composition and assess the senior independent director position at that time.

 

 

Outlook

It is very early in our financial year and our order book as usual remains at approximately one month's revenue. Whilst we may continue to experience unpredictable orders both in terms of size and timing we expect continued global investment in production systems and processes to lead to greater demand for the Group's products. We therefore continue to invest in our infrastructure, research and development and remain confident for the medium to longer-term prospects for the Group.

 

 

 

Sir David McMurtry CBE, RDI, FRS, FREng, CEng, FIMechE

Chairman and Chief Executive

 

17th October 2013

 

Renishaw plc

Registered office New Mills, Wotton-under-Edge, Gloucestershire, GL12 8JR

Registered number 1106260

Telephone number 01453 524524

Website www.renishaw.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSMRBLTMBABMJJ
Date   Source Headline
16th May 20239:45 amRNSAGM Voting Results Update Statement
9th May 20233:39 pmRNSNotice of Investor Day
28th Apr 20237:00 amRNSTrading Statement
2nd Feb 20237:00 amRNSHalf-year Report
24th Jan 20233:11 pmRNSNotice of Half-year Results
30th Nov 20224:38 pmRNSResult of AGM
31st Oct 20221:00 pmRNSNotice of AGM
28th Oct 20229:15 amRNSDirector/PDMR Shareholding
27th Oct 20227:00 amRNSTrading Statement
30th Sep 20227:00 amRNSAnnual Financial Report
29th Sep 202210:12 amRNSDirector/PDMR Shareholding
15th Sep 20227:00 amRNSFinal Results
6th Sep 20221:00 pmRNSNotice of Results
1st Jul 202212:31 pmRNSDirector Declaration
16th May 20225:56 pmRNSDirector/PDMR Shareholding
16th May 20227:00 amRNSAGM Voting Results Update Statement
10th May 20227:00 amRNSTrading Statement
12th Apr 202211:44 amRNSNotice of Investor Day
12th Apr 202210:58 amRNSDirector/PDMR Shareholding
31st Mar 20221:00 pmRNSDirectorate Change
18th Mar 20222:08 pmRNSHolding(s) in Company
14th Mar 20225:58 pmRNSDirector/PDMR Shareholding
1st Mar 20224:23 pmRNSDirectorate Change
3rd Feb 20227:00 amRNSHalf-year Report
17th Jan 20221:00 pmRNSNotice of Half-year Results
20th Dec 20214:05 pmRNSDirectorate Change
24th Nov 20213:57 pmRNSResult of AGM
29th Oct 20218:00 amRNSDirector/PDMR Shareholding
29th Oct 20217:00 amRNSAnnual Financial Report
21st Oct 202111:50 amRNSFinal Results Replacement
21st Oct 20217:00 amRNSFinal Results
21st Oct 20217:00 amRNSTrading Statement
27th Sep 202110:52 amRNSFinal Results Revised Date and Trading Update
17th Sep 202110:35 amRNSNotice of Results
31st Aug 202112:31 pmRNSHolding(s) in Company
3rd Aug 20213:05 pmRNSDirector/PDMR Shareholding
8th Jul 20213:20 pmRNSForm 8.3 - Renishaw plc
8th Jul 20217:00 amRNSForm 8.3
7th Jul 20213:20 pmRNSForm 8.3 - Renishaw plc
7th Jul 20213:13 pmRNSForm 8.3 - Renishaw plc
7th Jul 20212:26 pmEQSForm 8.3 - The Vanguard Group, Inc.: Renishaw plc
7th Jul 202111:48 amRNSForm 8.5 (EPT/NON-RI) - Renishaw plc
7th Jul 202111:14 amRNSForm 8.5 (EPT/RI) - Renishaw Plc
7th Jul 20217:00 amRNSUpdate on Formal Sale Process & Current Trading
6th Jul 20213:20 pmRNSForm 8.3 - Renishaw plc
6th Jul 20213:09 pmRNSForm 8.3 - Renishaw plc
6th Jul 20212:38 pmRNSForm 8.3 - Renishaw Plc
6th Jul 20212:13 pmRNSForm 8.3 - Renishaw Plc
6th Jul 20212:05 pmEQSForm 8.3 - The Vanguard Group, Inc.: Renishaw plc
6th Jul 202111:36 amRNSForm 8.5 (EPT/RI) - Renishaw Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.